JAG1 and amyotrophic lateral sclerosis: Indeed, a mouse model of Jag1 inhibition specifically in astrocytes causes an increase in disease severity and a decrease in motor neuron viability as well as an increase in NOTCH pathway activation in astrocytes suggesting a beneficial role for NOTCH pathway activation in ALS (15).